We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




Groundbreaking Tool Accurately Predicts Stroke Outcome for Better Carotid Surgery Decisions

By HospiMedica International staff writers
Posted on 31 Jan 2025

Stroke continues to be a significant global health concern, ranking as the second leading cause of mortality worldwide. More...

Timely intervention is crucial for stroke patients, with carotid endarterectomy (CEA) and carotid artery stenting (CAS) being increasingly utilized in select cases of acute carotid-related stroke. In response to this, researchers have developed a predictive model that boasts a 93% accuracy rate in determining whether patients undergoing urgent carotid interventions will regain functional independence.

This innovative model, developed by researchers at Ochsner Health (New Orleans, LA, USA), employs a data-driven approach that integrates four key clinical metrics—stroke severity, frailty risk score, timing of intervention, and the use of thrombolysis. By combining these elements into a real-time decision-making tool, clinicians can proactively assess who will benefit from immediate surgery and who may require “pre-habilitation” to optimize surgical outcomes. The frailty risk score is integrated into the electronic medical record (EMR), alongside stroke severity and other pertinent data, providing a comprehensive view of the patient’s condition.

By leveraging this model, healthcare providers can tailor treatment strategies, optimize intervention timing, and ensure that the most suitable patients receive these complex procedures. The swift action required in stroke care makes it essential for clinicians to make informed decisions quickly. As highlighted in the Journal of the American College of Surgeons, incorporating this predictive model into standard clinical workflows will equip healthcare teams with the tools needed to anticipate patient outcomes more accurately. This approach enables patient-centered care, enhancing short-term recoveries and improving long-term quality of life.

“Predicting a patient’s recovery potential with such reliability gives us an unprecedented level of confidence in our treatment decisions,” said Leo Seoane, MD, executive vice president and chief academic officer at Ochsner Health and founding dean for the Xavier Ochsner College of Medicine. “This innovation ensures that every patient receives the care best suited to their situation, further advancing our commitment to excellence.”

Related Links:
Ochsner Health


Gold Member
12-Channel ECG
CM1200B
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
New
Steam Sterilizer
AMSCO 400 Series
New
Ultrasonic Dissector
SONICBEAT
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: New clinical guidance suggests treatments to prevent blood clots in CLTI patients after leg artery procedures (Photo courtesy of Shutterstock)

Stronger Blood Clot Prevention Measures Needed After Leg Artery Procedures in High-Risk Patients

Chronic limb-threatening ischemia (CLTI), the most severe form of peripheral artery disease (PAD), significantly reduces blood flow to the legs and feet. Despite undergoing lower limb revascularization... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: A research collaboration aims to further advance findings in human genomics research in cardiovascular diseases (Photo courtesy of 123RF)

Bayer and Broad Institute Extend Research Collaboration to Develop New Cardiovascular Therapies

A research collaboration will focus on the joint discovery of novel therapeutic approaches based on findings in human genomics research related to cardiovascular diseases. Bayer (Berlin, Germany) and... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.